Insulin-like growth factor II stimulates glucose transport in human skeletal muscle

FEBS Lett. 1992 Aug 3;307(3):379-82. doi: 10.1016/0014-5793(92)80717-u.

Abstract

We investigated the effect of insulin-like growth factor II (IGF-II) and insulin-like growth factor binding protein-1 (IGFBP-1) on 3-O-methylglucose transport in incubated human skeletal muscle strips. Increasing physiological concentrations of IGF-II stimulated glucose transport in a dose-dependent manner. Glucose transport was maximally stimulated in the presence of 100 ng/ml (13.4 nM) of IGF-II, which corresponded to the effect obtained by 100 microU/ml (0.6 nM) of insulin. Exposure of muscle strips to IGFBP-1 (500 ng/ml) inhibited the maximal effect of IGF-II on glucose transport by 40%. Thus, it is conceivable that IGF-II and IGFBP-1 are physiological regulators of the glucose transport process in human skeletal muscle.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biological Transport / drug effects
  • Carrier Proteins / pharmacology
  • Glucose / metabolism*
  • Humans
  • In Vitro Techniques
  • Insulin-Like Growth Factor Binding Proteins
  • Insulin-Like Growth Factor II / pharmacology*
  • Male
  • Muscles / drug effects*
  • Muscles / metabolism
  • Somatomedins

Substances

  • Carrier Proteins
  • Insulin-Like Growth Factor Binding Proteins
  • Somatomedins
  • Insulin-Like Growth Factor II
  • Glucose